Swedish Firm Taps Biomodels for Predictive HSCT Study

Swedish Orphan Biovitrum wants Biomodels to test the potential for developing a personalized test for a complication caused by stem cell therapy regimens.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories